Company profile: Reva Medical
1.1 - Company Overview
Company description
- Provider of bioresorbable polymers and medical devices for vascular applications, including MOTIV Bioresorbable Scaffold for below-the-knee peripheral artery disease, Fantom Encore third-generation radiopaque coronary scaffold with thin struts, and TyroSphere bioresorbable embolic microspheres for hypervascular tumors, visible under standard x-ray; all built on the proprietary Tyrocore polymer.
Products and services
- Tyrocore: Proprietary, custom-engineered polymer developed for bioresorbable medical devices for vascular applications, serving as the material used in MOTIV scaffold
- Fantom Encore: Third-generation, medical-grade bioresorbable coronary scaffold featuring radiopacity and thin struts that enhance procedural visibility and ease of use for treating coronary artery disease
- MOTIV Bioresorbable Scaffold: Implant-grade peripheral scaffold constructed from Tyrocore polymer, engineered for treating below-the-knee peripheral artery disease in vascular applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Reva Medical
JenaValve
HQ: United States
Website
- Description: Provider of transcatheter heart valve solutions, including the Trilogy Heart Valve System for TAVR to treat severe aortic regurgitation or stenosis, featuring a self-expanding nitinol frame and locator technology for precise placement. Offers the Trilogy Valve for secure anchoring without calcium, a Delivery System for precise deployment, and an 85cm pre-shaped Introducer Sheath for safe vascular access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full JenaValve company profile →
Precise Bio
HQ: United States
Website
- Description: Provider of regenerative medicine solutions, including 4D bio-fabricated corneas for transplantation, a 4D bio-fabrication platform that integrates tissue engineering, biomaterials, and cell technologies to create functional tissues and organs, and a 3D cardiac tissue patch for post-myocardial infarction to restore cardiac muscle viability and functionality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Precise Bio company profile →
Annexin Pharmaceuticals
HQ: Sweden
Website
- Description: Provider of biotechnology focused on Annexin A5-based therapeutics. Develops ANXV, a human recombinant Annexin A5 that targets phosphatidylserine for acute treatment of cardiovascular diseases and is being investigated for retinal vein occlusion, cancer, and sickle cell disease. ANXV aims to protect cells, modulate immune responses, and reduce vascular inflammation and cellular stress.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Annexin Pharmaceuticals company profile →
New Valve Technology
HQ: Switzerland
Website
- Description: Provider of medical devices for interventional cardiology and cardiac surgery, supporting minimally invasive treatment of valvular heart disease; develops, manufactures and markets these devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full New Valve Technology company profile →
Impella
HQ: Germany
Website
- Description: Provider of minimally invasive cardiovascular support systems for numerous indications in cardiology and coronary surgery. Based in Aachen, Germany, the company develops, manufactures and markets its technology, which is protected by more than 30 European and international patents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Impella company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Reva Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Reva Medical
2.2 - Growth funds investing in similar companies to Reva Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Reva Medical
4.2 - Public trading comparable groups for Reva Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →